Our aim is to keep investors and interested parties informed of Uscom news events and announcements
This partnership will provide increased manufacturing capacity, decreased manufacturing cost, increased global market access and world leading supply chain management. The agreement includes the manufacture of USCOM 1A and three new Uscom devices, and will expedite regulatory approvals and sales under the new local manufacturing requirements of China.
Five new global publications in maternal-fetal medicine, support USCOM 1A as the world leader for screening and diagnosis of maternal hypertension.
Uscom’s results for H1 FY22 are healthy considering the global headwinds, and despite falling short of our forecasts.
Uscom attended the 8th AIPE (Associazione Italiana PreEclampsia) National Congress in Italy, which was sponsored by our Italian distributor Vega. The conference is dedicated to the screening, early prediction, prevention, therapy and follow-up of hypertensive disorders in pregnancy.
